China · Delayed Price · Currency is CNY Wuhan Hvsen Biotechnology Statistics
Total Valuation
SHE:300871 has a market cap or net worth of CNY 5.48 billion. The enterprise value is 5.31 billion.
| Market Cap | 5.48B |
| Enterprise Value | 5.31B |
Important Dates
The next estimated earnings date is Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
SHE:300871 has 201.58 million shares outstanding. The number of shares has increased by 8.54% in one year.
| Current Share Class | 201.58M |
| Shares Outstanding | 201.58M |
| Shares Change (YoY) | +8.54% |
| Shares Change (QoQ) | +7.56% |
| Owned by Insiders (%) | 5.20% |
| Owned by Institutions (%) | 2.48% |
| Float | 106.67M |
Valuation Ratios
The trailing PE ratio is 22.79 and the forward PE ratio is 30.54.
| PE Ratio | 22.79 |
| Forward PE | 30.54 |
| PS Ratio | 3.29 |
| PB Ratio | 2.59 |
| P/TBV Ratio | 2.74 |
| P/FCF Ratio | 45.11 |
| P/OCF Ratio | 25.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.59, with an EV/FCF ratio of 43.70.
| EV / Earnings | 24.64 |
| EV / Sales | 3.18 |
| EV / EBITDA | 15.59 |
| EV / EBIT | 22.81 |
| EV / FCF | 43.70 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.70 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | 2.57 |
| Interest Coverage | 11.29 |
Financial Efficiency
Return on equity (ROE) is 12.22% and return on invested capital (ROIC) is 10.62%.
| Return on Equity (ROE) | 12.22% |
| Return on Assets (ROA) | 4.95% |
| Return on Invested Capital (ROIC) | 10.62% |
| Return on Capital Employed (ROCE) | 10.51% |
| Revenue Per Employee | 1.62M |
| Profits Per Employee | 209,542 |
| Employee Count | 1,028 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.88 |
Taxes
In the past 12 months, SHE:300871 has paid 30.49 million in taxes.
| Income Tax | 30.49M |
| Effective Tax Rate | 12.35% |
Stock Price Statistics
The stock price has increased by +169.64% in the last 52 weeks. The beta is 0.57, so SHE:300871's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +169.64% |
| 50-Day Moving Average | 21.86 |
| 200-Day Moving Average | 22.41 |
| Relative Strength Index (RSI) | 62.58 |
| Average Volume (20 Days) | 16,510,311 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300871 had revenue of CNY 1.67 billion and earned 215.41 million in profits. Earnings per share was 1.19.
| Revenue | 1.67B |
| Gross Profit | 434.22M |
| Operating Income | 232.65M |
| Pretax Income | 246.82M |
| Net Income | 215.41M |
| EBITDA | 340.34M |
| EBIT | 232.65M |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 492.86 million in cash and 311.61 million in debt, with a net cash position of 181.25 million or 0.90 per share.
| Cash & Cash Equivalents | 492.86M |
| Total Debt | 311.61M |
| Net Cash | 181.25M |
| Net Cash Per Share | 0.90 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 10.46 |
| Working Capital | 525.17M |
Cash Flow
In the last 12 months, operating cash flow was 217.94 million and capital expenditures -96.47 million, giving a free cash flow of 121.46 million.
| Operating Cash Flow | 217.94M |
| Capital Expenditures | -96.47M |
| Free Cash Flow | 121.46M |
| FCF Per Share | 0.60 |
Margins
Gross margin is 26.04%, with operating and profit margins of 13.95% and 12.92%.
| Gross Margin | 26.04% |
| Operating Margin | 13.95% |
| Pretax Margin | 14.80% |
| Profit Margin | 12.92% |
| EBITDA Margin | 20.41% |
| EBIT Margin | 13.95% |
| FCF Margin | 7.28% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.74%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.74% |
| Dividend Growth (YoY) | -23.55% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 26.33% |
| Buyback Yield | -8.54% |
| Shareholder Yield | -7.91% |
| Earnings Yield | 3.93% |
| FCF Yield | 2.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 10, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | May 10, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300871 has an Altman Z-Score of 3.54 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 8 |